Supply of Weight Loss Drug Wegovy Expected to Improve in Next Few Months Company Says
Sort by
Date
Items per page
-
First Medicare Health Plans to Start Paying for Weight-Loss Drug Wegovy
The first major U.S. health insurers have agreed to start paying for the popular anti-obesity drug Wegovy for certain people on Medicare with heart-related conditions.The Wall Street Journal - World -
Wegovy will be covered by some insurers, but not for weight loss: report
Some large health insurers in the U.S. will start covering Wegovy, which has become a popular anti-obesity drug — but not for those using it to lose weight, according to a report in The Wall Street Journal.MarketWatch - Business -
Altimmune says weight loss drug minimized muscle loss in trial results, which may set it apart
The results are a sign that Altimmune can address an area of concern around weight loss drugs, which is that they shrink critical muscle mass.CNBC - Business -
Burden falls on Prince William to steer monarchy through next few months
With his father and wife diagnosed with cancer, and himself estranged from his once beloved brother, the blows have come thick and fast. For the Prince of Wales, the blows have come swiftly one after the other. First his father, King Charles, ...The Guardian - World -
Amgen wants in on the booming weight loss drug market — and it's taking a different approach
Amgen is testing a monthly injection that works differently and appears to help patients maintain their weight loss even after they stop taking it.CNBC - Business -
US-China Decoupling Poses Supply Chain Risks for Drug Companies
A proposed bill in Congress targets Chinese biotech businesses that play an important role in developing drugs.The Wall Street Journal - World -
Here's how much people are willing to spend on weight loss drugs, according to a new survey
Some patients are willing to pay more for GLP-1 weight loss drugs like Wegovy than others — and it's strongly correlated to their annual income.CNBC - Business -
Viking Therapeutics posts positive results for oral weight-loss drug. Analysts remain unanimous the stock’s a buy.
Data from a Phase 1 trial is the latest bullish news from the biotech that may offer cheap entry to weight-loss mania.MarketWatch - Business -
Eli Lilly climbs on win for rival weight-loss drug, and we still feel good about Abbott Labs
Every weekday, the Investing Club releases the Homestretch; an actionable afternoon update just in time for the last hour of trading.CNBC - Business -
This small-cap stock is expected to take off — if its weight-loss pill trial succeeds
Terns Pharma is due to release data from an early-stage trial of an obesity treatment in pill form in the second half. Positive data would send the stock higher.MarketWatch - Business -
House to send impeachment articles to Senate next month
House Speaker Mike Johnson announced the impeachment articles for Alejandro Mayorkas will be sent over to the Senate on April 10ABC News - Top stories -
Patients Hate ‘Forever’ Drugs. Are Ozempic and Wegovy Different?
The new obesity drugs might be an exception to a chronic, deadly problem: the failure to stick with medication.The New York Times - Health -
March Madness: After loss to Gonzaga, KU's Bill Self admits he's 'been thinking about next season' for the past month
Self made it clear that he wasn't bullish on Kansas' national title chances as the Jayhawks struggled down the stretch.Yahoo Sports - Sports -
Medicare can pay for obesity drugs like Wegovy in certain heart patients
Certain Medicare patients may get help paying for the popular weight-loss drug Wegovy, as long as they also have heart diseaseABC News - Health -
Germany, freed from weight of expectation, are ready to fly
The Euro 2024 hosts have not won a knockout game in eight years, but might just be set for a resurgence.ESPN - Sports -
Aluminum company says preferred site for new smelter is a region of Kentucky hit hard by job losses
Gov. Andy Beshear says an aluminum company has singled out northeastern Kentucky as its preferred site for a new aluminum smelterABC News - Top stories -
Another CEO is leaving Discover. The company says he wasn’t expected to be there very long anyway.
Michael Rhodes, who is taking the CEO job at Ally Financial, was “not expected to have a long-term role” as Discover’s tie-up with Capital One looms.MarketWatch - Business -
Two fresh ways to play the weight loss and megacap tech hype
A major exchange-traded fund provider is going deep on two popular plays: megacap tech and weight loss drug stocks.CNBC - Business -
Viking Therapeutics stock jumps more than 15% on promising weight loss pill data
The Viking study results add to the growing excitement around the biotech company and its potential in the budding weight loss market.CNBC - Business -
The Next Generation of Cancer Drugs Will Be Made in Space
Injectable immunotherapy drugs can be made, in theory, but gravity prevents them from crystallizing correctly. A startup thinks the solution could be right above us.Wired - Tech -
Merck's $11.5 Billion Bet on Its Next Big Drug Finally Arrives
The newly approved drug, which treats potentially fatal pulmonary arterial hypertension, is estimated to ring up as much as $7.5 billion in yearly sales.The Wall Street Journal - Business -
Companies Are Seeking Real-World Supply-Chain Gains in New AI Tools
Logistics firms are targeting cost savings as well as faster and more efficient deliveries as they incorporate generative AI into operations.The Wall Street Journal - World -
Senegal to elect its next president after months of unrest
Yahoo News - World -
Senegal voted in a tightly contested presidential race after months of unrest
Senegalese have voted in a tightly contested presidential race following months of uncertainty and unrest that have tested the West African nation’s reputation as a stable democracy in a coup-prone regionABC News - World -
These airports could be affected during next month's solar eclipse
"It's going to be hectic but fun. Go with the mindset that it's going to be busy and pack light," said one aviation expert.CBS News - Top stories -
Novo Nordisk's $1,000 diabetes drug Ozempic can be made for less than $5 a month, study suggests
Researchers found Novo Nordisk's Ozempic could be manufactured for an estimated 89 cents to $4.73 for a month's supply, figures that include a profit margin.CNBC - Business -
RH expects furniture demand to improve, after ‘the most challenging housing market in three decades’
Shares of RH rallied after hours on Wednesday, after the luxury furniture chain said it expected demand to pick up through this year, after contending with what it said was “the most challenging housing market in three decades.”MarketWatch - Business -
Oil prices end lower, with weekly U.S. crude supply up over 3 million barrels
Oil futures declined on Wednesday but settled off the session’s lows after official U.S. data revealed a weekly increase in crude inventories that was smaller than what was reported by an industry trade group.MarketWatch - Business -
Boeing's Next CEO Will Have 'Massive Job' at Company in Crisis
David Calhoun was brought in to fix Boeing’s issues, but he will leave a big repair job for the next leader.The Wall Street Journal - World -
Boeing's Next CEO Will Have 'Massive Job' at Company in Crisis
David Calhoun was brought in to fix Boeing’s issues, but he will leave a big repair job for the next leader.The Wall Street Journal - Business -
Tech companies anticipating the enormous quantities of electricity that will be needed to power the advance of artificial intelligence are looking to utilities for reassurance about supplies.
Tech companies anticipating the enormous quantities of electricity that will be needed to power the advance of artificial intelligence are looking to utilities for reassurance about supplies.The Wall Street Journal - World -
Volkswagen workers to vote on union representation next month in the 1st test of recruiting drive
Workers at Volkswagen’s factory in Chattanooga, Tennessee, will vote next month on whether they want to be represented by the United Auto Workers unionABC News - Top stories -
Motorola Edge 50 Pro with Snapdragon 7 Gen 3 is launching early next month
Yahoo News - World -
Morning Report: Trump notches legal win; first trial starts next month
The first criminal trial of a former president is now pinned to a calendar ahead of Election Day. After various delays, jury selection will begin April 15 in former President Trump’s hush money trial, a judge ruled Monday in a case brought by ...The Hill - Politics - Donald Trump -
V Rising's Castlevania Crossover Challenges You To Kill Simon Belmont Next Month
Castlevania is making another video game comeback, this time as crossover content with the upcoming 1.0 launch of game V Rising. As part of the vampiric survival game's full launch in May, this free update will allow players to pit their demonic ...GameSpot - Tech -
Baltimore Bridge Disaster Won't Snarl Supply Chains, Experts Say
The catastrophic collapse of the Francis Scott Key Bridge will upend area traffic, but flows of shipped goods can be rerouted to other ports.Inc. - Business -
Cramer says Washington's antitrust fights against Big Tech don't hold weight
CNBC's Jim Cramer on Monday told investors he disagrees with the government's antitrust lawsuits against mega cap tech companies.CNBC - Business -
Tennessee Company Hired Children to Operate ‘Dangerous’ Machinery, Officials Say
Tuff Torq Corp. of Morristown, Tenn., must pay a fine of nearly $300,000 and set aside $1.5 million in profits to compensate 10 underage workers, the Labor Department said.The New York Times - Business -
Merck is making a big bet that its new drug approved in the U.S. for a potentially fatal lung disease will fill a revenue hole expected when one of its patents expires in 2028.
Merck is making a big bet that its new drug approved in the U.S. for a potentially fatal lung disease will fill a revenue hole expected when one of its patents expires in 2028.The Wall Street Journal - World -
Drug overdoses reach another record with almost 108,000 Americans in 2022, CDC says
Nearly 108,000 Americans died of drug overdoses in 2022ABC News - Health